Government Signs Pact to Revive IDPL, to Provide Need-Based Funds
The government has agreed to provide funds on a need based basis to revive sick public sector pharmaceutical undertaking Indian Drugs and Pharmaceuticals Limited (IDPL).
A Memorandum of Understanding (MoU) has been signed between Department of Pharmaceuticals and IDPL to make it a 'vibrant drug manufacturing company', setting targets, including to achieve at least 5 per cent growth in sales and 5 per cent reduction in inventory of finished goods over 2013-14.
IDPL's sales turnover is estimated to be Rs 63 crore and a net loss of Rs 309.01 crore as on March 31, 2014.
According to the MoU, the government support is being provided with the aim to manufacture and supply essential medicines, and generic drugs for supply to central and state government organisations and pharmacies at reasonable prices.
It further said, the other objective is to help meet the emergency needs of the country for supply of medicines during natural calamities.
As per the MoU, government support would also help to modernise, upgrade and improve production facilities in tablet and capsule section at Rishikesh, Chennai and Gurgaon plants.
Draft Rehabilitation Scheme (DRS) for revival of IDPL has been submitted and cabinet note for revival is on process.
An action plan for implementation and monitoring of the MoU has also been signed under which IDPL will monitor monthly and quarterly implementation of the pact, while Department of Pharmaceuticals will do the same for the half year.
The Department of Public Enterprises has been entrusted with monitoring the implementation of MoU on a yearly basis.
IDPL is the largest central pharma public sector undertaking in India with plants at Rishikesh, Gurgaon & Hyderabad and two subsidiary units at Chennai and Muzaffarpur.
It was formally declared sick by the Board for Industrial & Financial Reconstruction (BIFR) on August 12, 1992.
-
Extracting Value From Battery Scrap Could Be Challenging For India | The Reason Why
A discarded lithium-ion battery still contains valuable materials such as lithium, nickel and cobalt. These can be recovered and reused. When such batteries are crushed and shredded, they produce a dark powder called black mass.
-
One El Nino, India Can Handle. Two Could Break The Granary
India's grain stocks can absorb one bad year, but a second El Nino could drain the buffer in two to three years, economists say.
-
India's Troika Of Good Luck | Joining The Dots
As Jensen Huang's exit drags Nvidia down, a cooling AI trade and resilient earnings have revived investor interest in India. A likely RBI rate hike looms.
-
Talking Points This Week: Leadership Shock At Nvidia, Earnings Strength, And The Fog Over Hormuz
The Anthropic IPO pricing and first trading day, Nvidia's upcoming earnings, and any fresh signals from Iran will set the tone for the following week.
-
Signature Play: The Classic Cocktail Is Dead. Or Is It?
Classic cocktails are disappearing from India's cocktail menus. But they're still being ordered, taught to bartenders and borrowed from. So, who's really having the last drink?
-
A New Samvat Wishlist: Inclusive Prosperity And Human Development
India has strengthened its economic foundations through infrastructure, digital access and enterprise. Its next growth chapter must deepen productivity, create better livelihoods and widen participation in prosperity.
-
Love, Sex Aur Dhokha: The Audacious Plot To Spy On Jensen Huang
A Taipei dinner, a Singapore chip buyer and a suspected Chinese asset: inside the alleged spy operation that got close to NVIDIA's Jensen Huang.
-
Ten Things I Learnt This Samvat
Patience can be a trap. Cheap stocks can stay cheap. Leverage can wipe you out. What did Samvat 2082 teach us? Niraj Shah writes on 10 lessons from the year gone by.
-
Talking Points This Week: Tech Nerves, FII Buying, And A Faraway Banking Shock
The global markets are not shining this Diwali. The exception in the large markets is, India.
-
Midterm Rally Lasted A Day. The Hard Reality Of A Divided US May Last Two Years | Opinion
Between a contested AI boom, a debt ceiling that arrives in 2027 and a president with every incentive to act alone, the next two years may prove more volatile than the first day's rally suggests.